Elevance Health Stock Rises After Earnings Top Expectations, Guidance Boosted

Stock At Highest Level Since Late 2022

By
Bill McColl
Bill McColl
Full Bio

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of the most notable news stories of the time.

Learn about our editorial policies
Published April 18, 2024
Elevance Health logo on a smartphone screen

Rafael Henrique / SOPA Images / LightRocket via Getty Images

Key Takeaways

  • Elevance Health exceeded earnings and revenue estimates for the first quarter and raised its outlook as it reported lower costs.
  • The health insurer said it lowered its benefit expense ratio by 20 basis points and increased its total operating margin to 7.1%.
  • Elevance shares were up nearly 4% in late trading Thursday, at their highest level since late 2022.

Shares of Elevance Health (ELV) rose to their highest level since late 2022 on Thursday as the health insurance provider posted better-than-expected results and raised its guidance amid lower costs.

Elevance reported first-quarter earnings per share (EPS) of $10.64, with revenue increasing 0.9% to $42.3 billion. Both were higher than analysts' estimates.

The company’s benefit-expense ratio, which measures the cost of claims to premiums, was 85.6%, an improvement of 20 basis points (bps) that also beat forecasts. Elevance said that the gain was “driven primarily by premium rate adjustments to cover medical cost trend in our Health Benefits business.”

Revenue from premiums slipped 0.5% to $35.7 billion, while benefit expenses were down 0.8% to $30.55 billion. Total operating margin rose to 7.1% from 6.8% last year. 

CEO Gail Boudreaux said the results “reflect disciplined execution of our strategic initiatives during a dynamic time for our industry.”

The company now anticipates full-year EPS of greater than $37.20, up from its previous outlook of greater than $37.10.

Elevance Health shares traded at their highest level since December 2022 on Thursday afternoon, up 3.8% at $528.26 at about 3:45 p.m. ET

Elevance stock chart

TradingView
Do you have a news tip for Investopedia reporters? Please email us at
Article Sources
Investopedia requires writers to use primary sources to support their work. These include white papers, government data, original reporting, and interviews with industry experts. We also reference original research from other reputable publishers where appropriate. You can learn more about the standards we follow in producing accurate, unbiased content in our editorial policy.

  1. Elevance Health. "ELEVANCE HEALTH REPORTS FIRST-QUARTER 2024 RESULTS ."

  2. Elevance Health. "ELEVANCE HEALTH REPORTS RESULTS FOR FOURTH-QUARTER AND FULL-YEAR 2023; SETS FULL YEAR 2024 OUTLOOK."

Take the Next Step to Invest
×
The offers that appear in this table are from partnerships from which Investopedia receives compensation. This compensation may impact how and where listings appear. Investopedia does not include all offers available in the marketplace.